Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121981512 | 12198151 | 2 | F | 20160229 | 20160426 | 20160322 | 20160831 | PER | US-JNJFOC-20160227752 | JANSSEN | 51.29 | YR | A | F | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121981512 | 12198151 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | FES09ME | 125261 | 45 | MG | SOLUTION FOR INJECTION | |||||
| 121981512 | 12198151 | 2 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 500 | MG | UNSPECIFIED | QOD | |||||||
| 121981512 | 12198151 | 3 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 0 | 100 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121981512 | 12198151 | 1 | Product used for unknown indication |
| 121981512 | 12198151 | 2 | Diabetes mellitus |
| 121981512 | 12198151 | 3 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121981512 | 12198151 | Accidental exposure to product | |
| 121981512 | 12198151 | Drug dose omission | |
| 121981512 | 12198151 | Product quality issue | |
| 121981512 | 12198151 | Syringe issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |